Flagship explainer
What drives MARKER THERAPEUTICS, INC.’s return on equity?
ROE is five filed business factors multiplied together.
| Input | Value | Fiscal year | Source |
|---|---|---|---|
| −$12.2M | FY2025 |
| |
| Income before tax | −$12.2M | FY2025 |
|
| Operating income | −$12.9M | FY2025 |
|
| $3.5M | FY2025 |
| |
| Ending assets | $19.1M | FY2025 |
|
| Beginning assets | $22M | FY2024 |
|
| $16.8M | FY2025 |
| |
| $18.6M | FY2024 |
|
Source:
- SEC filingFiling detailsAccession 0001104659-26-031274